<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02164773</url>
  </required_header>
  <id_info>
    <org_study_id>use of magnesium sulfate</org_study_id>
    <nct_id>NCT02164773</nct_id>
  </id_info>
  <brief_title>Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation.</brief_title>
  <official_title>Addition of Magnesium Sulfate to Caudal for Prevention of Emergence Agitation in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence agitation after sevoflurane anesthesia is still a problem needed to be solved.The
      aim of the study is to delineate the effect of caudal magnesium sulfate in children
      undergoing lower abdominal surgery to prevent postoperative emergence agitation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emergency agitation is considered one of the postoperative complication after sevoflurane
      anesthesia.In the enrollment of this study,children undergoing lower abdominal surgery will
      be enrolled in one of two groups.BM group, receive caudal magnesium sulfate 50 mg beside the
      conventional bupivacaine in the caudal space in ,B group, addition of 1 ml of normal
      saline0.9% to bupivacine .Monitoring of the postoperative emergence agitation by different
      emergence agitation scores with monitoring of sedation score.Detection of expected
      postoperative complications as nausea and vomiting.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measure of postoperative pediatric anesthesia emergence delirium PAED score</measure>
    <time_frame>first 30 minutes postoperative</time_frame>
    <description>measurement of PAED score every 5 minutes in the first 30 minutes after lower abdominal surgery in children 1-6 year age after sevoflurane anesthesia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measure of postoperative sedation score.</measure>
    <time_frame>the first 30 minutes postoperatively</time_frame>
    <description>use of sedation score as a measure of postoperative sedation expected after caudal magnesium sulfate every 5 minutes for 30 minutes after end of surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>postoperative rescue propofol intravenous 1mg/kg in cases if agitation</measure>
    <time_frame>first 30 minutes postoperative</time_frame>
    <description>if emergence agitation occur giving of 1mg/kg of intravenous propofol as rescue medication</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Agitation</condition>
  <condition>Pediatric Disorder</condition>
  <arm_group>
    <arm_group_label>magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>magnesium sulfate 50mg caudal 1ml(5%) prepared after addition of 9ml of 0.9%normal saline to 1ml of 500mg(50%)of magnesium sulfate to be added to 1ml/kg of 0.25%of bupivacaine in caudal block in children undergoing lower abdominal surgery under sevoflurane anesthesia to prevent emergence agitation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>o.9%normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% of normal saline added to the conventional 0.25% bupivacaine in caudal block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>use of 50mg magnesium sulfate in caudal analgesia added to 1ml/kg of 0.25% of bupivacaine in children undergoing lower abdominal surgery for prevention of postoperative emergence agitation.</description>
    <arm_group_label>magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9%normal saline</intervention_name>
    <description>use of 1ml of 0.9%normal saline added to 1ml/kg of 0.25% of bupivacaine in the caudal block as placebo to compare with active comparator.</description>
    <arm_group_label>o.9%normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children undergoing lower abdominal surgery for hernia repair/orchiopexy in Ain Shams
             University ASA physical status I under sevoflurane anesthesia.

          -  age from 1-6 years.

        Exclusion Criteria:

          -  children with developmental delay

          -  neurological disorder.

          -  psychological disorder

          -  difficult airway

          -  hyperactive airway disease

          -  contraindication to caudal block(sacral abnormality,bleeding disorder).
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alaa Elkateb, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ashraf elsayed elagamy, MD anesthesia</last_name>
    <phone>00966546683234</phone>
    <email>elagamy_ashraf@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>wael yahir</last_name>
    <email>waelibrahimtahir@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashraf Elagamy, MD anesthesia</last_name>
      <email>elagamy_ashraf@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>wael tahir, MDanesthesia</last_name>
      <email>waelibrahimtahir@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ashraf elagamy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/20833531</url>
  </link>
  <reference>
    <citation>Saadawy I, Boker A, Elshahawy MA, Almazrooa A, Melibary S, Abdellatif AA, Afifi W. Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics. Acta Anaesthesiol Scand. 2009 Feb;53(2):251-6. doi: 10.1111/j.1399-6576.2008.01818.x. Epub 2008 Dec 6.</citation>
    <PMID>19076110</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2014</study_first_submitted>
  <study_first_submitted_qc>June 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2014</study_first_posted>
  <last_update_submitted>June 13, 2014</last_update_submitted>
  <last_update_submitted_qc>June 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ashraf Elsayed Elagamy</investigator_full_name>
    <investigator_title>ashraf elagamy</investigator_title>
  </responsible_party>
  <keyword>sevoflurane</keyword>
  <keyword>pediatric</keyword>
  <keyword>lower abdominal surgery</keyword>
  <keyword>caudal</keyword>
  <keyword>magnesium sulfate</keyword>
  <keyword>Magnesium Sulfate Causing Adverse Effects in Therapeutic Use</keyword>
  <keyword>Agitation States as Acute Reaction to Exceptional Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

